BACKGROUND: Self-stigma is a maladaptive psychosocial phenomenon that can affect many areas of patients' lives and have a negative impact on their quality of life (QoL). This study explored the association between self-stigma, QoL, demographic data, and the severity of symptoms in patients with depressive disorder. PATIENTS AND METHODS: Patients who met the International Classification of Diseases, 10th revision, research criteria for depressive disorder were enrolled in this cross-sectional study. All outpatients completed the following measurements: the Quality of Life Enjoyment and Satisfaction Questionnaire, the Internalized Stigma of Mental Illness Scale, demographic questionnaire, and the objective and subjective Clinical Global Impression-Severity scales that measure the severity of disorder. A total of 81 depressive disorder patients (with persistent affective disorder - dysthymia, major depressive disorder, or recurrent depressive disorder) and 43 healthy controls participated in this study. RESULTS: Compared with the healthy control group, a lower QoL was observed in patients with depressive disorder. The level of self-stigma correlated positively with total symptom severity score and negatively with QoL. Multiple regression analysis revealed that the overall rating of objective symptom severity and score of self-stigma were significantly associated with QoL. CONCLUSION: This study suggests a lower QoL in patients with depressive disorder in comparison with healthy controls and a negative impact of self-stigma level on QoL in patients suffering from depressive disorders.

Department of Psychiatry Faculty of Medicine and Dentistry Palacky University Olomouc University Hospital Olomouc Olomouc

Department of Psychiatry Faculty of Medicine and Dentistry Palacky University Olomouc University Hospital Olomouc Olomouc; Department of Psychiatry Hospital Liberec Liberec Czech Republic

Department of Psychology Sciences Faculty of Social Science and Health Care Constantine the Philosopher University Nitra Slovak Republic

Zobrazit více v PubMed

Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc Sci Med. 2010;71(12):2150–2161. PubMed

Camp DL, Finlay WML, Lyons E. Is low self-esteem an inevitable consequence of stigma? An example of women with chronic mental health problems. Soc Sci Med. 2002;55(5):823–834. PubMed

Fung KMT, Tsang HWH, Corrigan PW. Self-stigma of people with schizophrenia as predictor of their adherence to psychosocial treatment. Psychiatr Rehabil J. 2008;32(2):485–495. PubMed

Ustündağ MF, Kesebir S. Internalized stigmatization in bipolar patients: relationship with clinical properties, quality of life and treatment compliance. Turk Psikiyatri Derg. 2013;24(4):231–239. PubMed

Corrigan PW, Rafacz J, Rüsch N. Examining a progressive model of self-stigma and its impact on people with serious mental illness. Psychiatry Res. 2011;189(3):339–343. PubMed PMC

Latalova K, Prasko J, Kamaradova D, et al. Self-stigma and suicidality in patients with neurotic spectrum disorder – a cross sectional study. Neuro Endocrinol Lett. 2014;35(6):474–480. PubMed

Schulze B, Angermeyer MC. Subjective experiences of stigma: a focus group study of schizophrenic patients, their relatives, and mental health professionals. Soc Sci Med. 2003;56(2):299–312. PubMed

Ritsher JB, Phelan JC. Internalized stigma predicts the erosion of morale among psychiatric outpatients. Psychiatry Res. 2004;129(3):257–265. PubMed

Tsang HW, Fung KM, Chung RC. Self-stigma and stages of change as predictors of treatment adherence of individuals with schizophrenia. Psychiatry Res. 2010;180(1):10–15. PubMed

Ociskova M, Prasko J, Vrbova K, Kamaradova D, Jelenova D, Latalova K. Stigma and self-stigma in patients with schizophrenia. Ceska Slov Psychiatr. 2014;110(5):250–258.

Ociskova M, Prasko J, Kamaradova D. Relationship between personality and self-stigma in mixed neurotic spectrum and depressive disorders – cross sectional study. Act Nerv Super Rediviva. 2015;57(1–2):22–29.

Ociskova M, Prasko J, Kamaradova D, Grambal A, Sigmundova Z. Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities. Neuropsychiatr Dis Treat. 2015;11:1767–1779. PubMed PMC

Ociskova M, Prasko J, Latalova K, Kamaradova D, Grambal A. Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients. Neuropsychiatr Dis Treat. 2016;12:1539–1551. PubMed PMC

WHO Preamble to the Constitution of the World Health Organization as Adopted by the International Health Conference; June 19–22, 1946; New York. Signed on 22 July 1946 by the representatives of 61 states (official records of the World Health Organization, Vol 2, 100) and entered into force on 7 April 1948.

WHOQOLG Measuring Quality of Life. 1997. [Accessed September 23, 2016]. Available from: http://www.who.int/mental_health/media/68.pdf.

Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry. 2005;162(6):1171–1178. PubMed

Ishak WW, Christensen S, Sayer G, et al. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study. J Clin Psychiatry. 2013;74(3):256–261. PubMed

Angermeyer MC, Holzinger A, Matschinger H, Stengler-Wenzke K. Depression and quality of life: results of a follow-up study. Int J Soc Psychiatry. 2002;48(3):189–199. PubMed

Hirschfeld RM, Dunner DL, Keitner G, et al. Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry. 2002;51(2):123–133. PubMed

Mcknight PE, Kashdan TB. The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research. Clin Psychol Rev. 2009;29(3):243–259. PubMed PMC

Berlim MT, Mcgirr A, Fleck MP. Can sociodemographic and clinical variables predict the quality of life of outpatients with major depression? Psychiatry Res. 2008;160(3):364–371. PubMed

Linzer M, Spitzer R, Kroenke K, et al. Gender, quality of life, and mental disorders in primary care: results from the PRIME-MD 1000 study. Am J Med. 1996;101(5):526–533. PubMed

Langlieb AM, Guico-Pabia CJ. Beyond symptomatic improvement: assessing real-world outcomes in patients with major depressive disorder. Prim Care Companion J Clin Psychiatry. 2010;12(2) PubMed PMC

Clifton J, Gingrich N. Are citizens of the world satisfied with their health? Health Aff (Millwood) 2007;26(5):w545–w551. PubMed

Wannamethee G, Shaper AG. Self-assessment of health status and mortality in middle-aged British men. Int J Epidemiol. 1991;20(1):239–245. PubMed

Lahelma E, Arber S, Kivela K, Roos E. Multiple roles and health among British and Finnish women: the influence of socioeconomic circumstances. Soc Sci Med. 2002;54(5):727–740. PubMed

Unden AL, Elofsson S. Do different factors explain self-rated health in men and women? Gend Med. 2006;3(4):295–308. PubMed

Ten Doesschate MC, Koeter MW, Bockting CL, Schene AH, DELTA Study Group Health-related quality of life in recurrent depression: a comparison with a general population sample. J Affect Disord. 2010;120(1–3):126–132. PubMed

Ishak WW, Balayan K, Bresee C, et al. A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting. Qual Life Res. 2013;22(3):585–596. PubMed

IsHak WW, Greenberg JM, Balayan K, et al. Quality of life: the ultimate outcome measure of interventions in major depressive disorder. Harv Rev Psychiatry. 2011;19(5):229–239. PubMed

IsHak WW, Mirocha J, James D, et al. Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up. Acta Psychiatr Scand. 2015;131(1):51–60. PubMed PMC

Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M. Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry. 2004;26(1):13–17. PubMed

EMEA 2002. [Accessed March 20, 2009]. Available from: http://www.ema.europa.eu/pdfs/human/ich/013595en.pdf.

Burgess RG. In the Field: An Introduction to Field Research. London: Routledge; 1991.

Ritsner M, Kurs R, Gibel A, Ratner Y, Endicott J. Validity of an abbreviated Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Qual Life Res. 2005;14(7):1693–1703. PubMed

Müllerova H. Transcultural transmission and validation of the quality life questionnaire Q-LES-Q (in Czech: Mezikulturní přenos a validace dotazníku kvality života Q-LES-Q) Psychiatrie. 2001;5:80–87.

Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res. 2003;121(1):31–49. PubMed

Boyd JE, Adler EP, Otilingam PG, Peters T. Internalized Stigma of Mental Illness (ISMI) Scale: a multinational review. Compr Psychiatry. 2014;55(1):221–231. PubMed

Ritsner M, Ben-Avi I, Ponizovsky A, Timinsky I, Bistrov E, Modai I. Quality of life and coping with schizophrenia symptoms. Qual Life Res. 2003;12(1):1–9. PubMed

Ociskova M, Prasko J, Dostalova L, et al. Self-stigma in psychiatric patients – standardization of the ISMI scale. Neuro Endocrinol Lett. 2014;35(7):624–632. PubMed

Guy W, editor. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: DHEW; 1976. Available from: https://archive.org/details/ecdeuassessmentm1933guyw.

Zaider TI, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR. Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychol Med. 2003;33(4):611–622. PubMed

Jansen K, Campos Mondin T, Azevedo Cardoso TD, et al. Quality of life and mood disorder episodes: community sample. J Affect Disord. 2013;147(1–3):123–127. PubMed

Lenox-Smith A, Macdonald MT, Reed C, et al. Quality of life in depressed patients in UK primary care: the FINDER study. Neurol Ther. 2013;2(1–2):25–42. PubMed PMC

Sivertsen H, Bjørkløf GH, Engedal K, Selbæk G, Helvik AS. Depression and quality of life in older persons: a review. Dement Geriatr Cogn Disord. 2015;40(5–6):311–339. PubMed

Sidlova M, Prasko J, Jelenova D, et al. The quality of life of patients suffering from schizophrenia – a comparison with healthy controls. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155(2):173–180. PubMed

Holubova M, Prasko J, Latalova K, et al. Are self-stigma, quality of life, and clinical data interrelated in schizophrenia spectrum patients? A cross-sectional outpatient study. Patient Prefer Adherence. 2016;10:265–274. PubMed PMC

Ocisková M, Praško J, Kamarádová D, et al. Self-stigma in psychiatric patients – standardization of the ISMI scale. Neuro Endocrinol Lett. 2014;35(7):624–632. PubMed

Vrbová K, Kamarádová D, Látalová K, et al. Self-stigma and adherence to medication in patients with psychotic disorders – cross-sectional study. Neuro Endocrinol Lett. 2014;35(7):645–652. PubMed

Gerlinger G, Hauser M, De Hert M, Lacluyse K, Wampers M, Correll CU. Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions. World Psychiatry. 2013;12(2):155–164. PubMed PMC

Kamaradova D, Latalova K, Prasko J, et al. Connection between self-stigma, adherence to treatment, and discontinuation of medication. Patient Prefer Adherence. 2016;10:1289–1298. PubMed PMC

Tang IC, Wu HC. Quality of life and self-stigma in individuals with schizophrenia. Psychiatr Q. 2012;83(4):497–507. PubMed

Yen CF, Lee Y, Tang TC, Yen JY, Ko CH, Chen CC. Predictive value of self-stigma, insight, and perceived adverse effects of medication for the clinical outcomes in patients with depressive disorders. J Nerv Ment Dis. 2009;197(3):172–177. PubMed